Your metabolic health and comorbidities also matter
Secondly, efficacy is the core criterion for evaluating drugs, and currently, multi-target GLP-1 drugs have shown better efficacy
However, the study found compared to the placebo group: Participants treated with semaglutide exhibited a broad pattern of slower biological aging across epigenetic clocks linked to inflammation and blood, brain, heart, kidney, liver and metabolic health
For patients seeking to reduce sodium intake whilst maintaining flavour in cooking, evidence-based strategies include: Gradual reduction in salt use, allowing taste preferences to adapt over time Potassium-enriched salt substitutes (under medical supervision for those with kidney disease or taking certain medications) Fresh herbs, spices, lemon juice, and vinegar as flavour enhancers Home cooking to control sodium content, as processed and restaurant foods are major sodium sources When to seek medical advice : Patients with hypertension, heart failure, chronic kidney disease, or those taking medications that affect electrolyte balance (such as ACE inhibitors, angiotensin receptor blockers, diuretics, or potassium-sparing medications including spironolactone) should consult their GP or specialist before making significant changes to salt intake or using salt substitutes
Increasing prevalence of type 2 diabetes and obesity, High cost of therapy and reimbursement challenges Who are the major players in the GLP 1 Analogues Market
